Neolytica
Neolytica is an AI-driven healthcare analytics subsidiary of QPharma that sells enterprise SaaS for KOL mapping, HCP engagement, and expert-validated sentiment analysis to pharmaceutical Medical Affairs and Commercial teams.
- Company typePrivate
- Founded2022
- HeadquartersMorristown, United States
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
What Neolytica does
Neolytica is a privately held healthcare analytics company that builds AI-driven KOL mapping, HCP engagement, and sentiment analysis software for pharmaceutical and life sciences clients. Founded in March 2022 as a subsidiary of QPharma (established 1994) and headquartered in Morristown, NJ, the company sells two core products under the Ti Expert and NotifyMe brands, plus a Ti Risk module for opioid diversion detection. The platform combines AI/NLP processing of publications, clinical trials, conference proceedings, and social media across 100,000+ digital sources with human review by 300+ medical experts to deliver customized (not syndicated) expert databases, influence mapping, gap and landscape analyses, and a Next Best Dialogue recommendation layer that suggests personalized engagement actions.
Underlying technology spans text NLP, structured claims/Rx analysis, and multimodal expert-profile aggregation. Capabilities include sentiment tagging (Positive/Neutral/Negative), predictive identification of rising-star and bridge-builder KOLs, Influencer Relationship Management with automated compliance workflows, and multi-source social listening via the NotifyMe alerting service. Operations run across the US and India, and the platform already monitors data sources in markets including China. Neolytica monetizes through annual subscription enterprise SaaS contracts sold via direct field sales, with quote-based pricing not publicly disclosed.
The company targets Medical Affairs, Market Access, Commercial Marketing, and Commercial Sales teams within pharmaceutical organizations, and claims 12 of the top 20 pharmaceutical companies as customers. The single-team platform includes compliance firewalls separating Medical and Marketing use, addressing pharma's regulatory constraints. Leadership is anchored by Founder and President Badal Shah, who previously built the KOL mapping business at Veeva Systems. The firm has received recognition including Silicon India 'Most Promising Company' and IFAH Top 100 Healthcare Leader. No external funding rounds are disclosed, consistent with its operating-subsidiary status under QPharma.
Neolytica firmographics
Firmographics- Name
- Neolytica
- Legal name
- Neolytica
- Website
- https://neolytica.ai
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Neolytica is an AI-driven healthcare analytics subsidiary of QPharma that sells enterprise SaaS for KOL mapping, HCP engagement, and expert-validated sentiment analysis to pharmaceutical Medical Affairs and Commercial teams.
- Ownership category
- akta.pro rank
Neolytica industry classification
Industry- Product category
- Healthcare Analytics / Pharmaceutical KOL Intelligence Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)
Keywords
Where Neolytica is headquartered
LocationHeadquarters
- HQ city
- Morristown
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Neolytica business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- SaaS Platform Subscriptions: Neolytica operates as a SaaS-based KOL mapping platform provider for pharmaceutical companies. The platform is sold as a subscription service to pharmaceutical and life sciences organizations for KOL identification, mapping, and engagement measurement.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS platform for pharmaceutical companies |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels9 records
Neolytica product offering
Product offeringCore offering
Neolytica sells an AI-driven SaaS healthcare analytics platform that helps pharmaceutical and life sciences organizations identify, map, and engage Key Opinion Leaders (KOLs) and Health Care Professionals (HCPs). The platform combines AI/ML and NLP with 300+ medical experts for sentiment analysis across 100,000+ digital platforms, and includes compliance firewalls separating Medical Affairs and Commercial Marketing use cases. Its core products are Ti Expert (KOL mapping and engagement planning) and NotifyMe (real-time social listening and email alerts).
Product overview
Neolytica is a healthcare analytics company offering a unified SaaS platform for KOL mapping and HCP engagement. The core platform combines Ti Expert for comprehensive expert identification and engagement planning with NotifyMe for real-time social listening and alerting. These products work together to help pharmaceutical and life science organizations identify Key Opinion Leaders (KOLs), Digital Opinion Leaders (DOLs), and local healthcare influencers, track their sentiment and behavior, and drive personalized engagement strategies. The platform serves Medical Affairs, Market Access, Commercial Marketing, and Commercial Sales teams with compliant firewalls between functions.
Differentiator
Problem solved
Functional benefit
Brands
- Ti Expert: Platform providing comprehensive data about Key Opinion Leaders, Community Opinion Leaders, and their promotional activities and spheres of influence.
- NotifyMe
- Ti Risk
Products and services
- Ti Expert Ti Expert is a KOL mapping and expert engagement platform for pharmaceutical and life sciences companies. It provides comprehensive data about validated medical professionals including professional spheres of influence, social relationships, and promotional activities. Features include KOL influence mapping and engagement planning, gap analysis, landscape analysis, message mapping, and identification of rising stars and bridge builders.
- NotifyMe NotifyMe is a healthcare KOL engagement service with email alerts that enables enterprise-scale social listening and provides actionable alerts on healthcare stakeholders in a desired therapeutic area. It offers sentiment tracking, multiple data source screening, and combines technology with human intelligence to provide snapshots of latest and upcoming information on KOLs of interest.
- Ti Risk Ti Risk is a platform that identifies prescribers and patients who may be involved in the diversion of opioids, designed for pharmaceutical companies operating in controlled substance therapeutic areas.
Quantifiable outcome
- Top 10% of KOLs identified through AI-driven approach impact 60% of target demographics
- +1 more outcomes
Companies that use Neolytica
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles4 records
Neolytica technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature5 records
Neolytica partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- QPharmacoreQPharma is the parent company of Neolytica. Founded in 1994, QPharma is an industry leader in cloud-based software and services for life sciences, providing solutions including sample management, product launch management, online training, and HCP/KOL targeting and engagement. Neolytica operates as a subsidiary, filling a gap in the industry by creating a single platform for Medical, Marketing, and Commercial teams.
Scale indicators10 records
Recent moves7 records
Expansion highlights5 records
Neolytica competitors and assessment
Company assessmentEmerging players
- Aktana: Aktana offers AI-driven commercial engagement and next-best-action intelligence for life sciences, overlapping with Neolytica's Next Best Dialogue feature and AI-driven personalization for pharma field teams.
- Komodo Health: Komodo Health provides healthcare data and analytics, including patient journey, HCP, and claims-based insights for life sciences, with partial overlap to Neolytica's Rx data, referral pattern, and patient journey capabilities.
Direct peers
- Within3: Within3 is a dedicated KOL and HCP engagement platform for pharma and life sciences, offering virtual advisory boards, stakeholder insights, and engagement analytics that directly compete with Neolytica's Ti Expert and NotifyMe solutions for Medical Affairs and Commercial Marketing buyers.
- Monocl: Monocl provides expert profile data and KOL analytics for the life sciences industry, including publication, grant, and clinical trial intelligence. It competes directly with Neolytica's data aggregation capabilities across scientific publications and conferences.
- Alpha Sophia: Alpha Sophia is an HCP intelligence platform offering clinician profiling, referral pattern analysis, and KOL mapping for pharma commercial teams, directly overlapping with Neolytica's Rx data, referral pattern, and HCP targeting use cases.
- H1: H1 is a healthcare professional data platform providing expert profiles, KOL identification, and clinical trial investigator insights that directly overlap with Neolytica's expert mapping and sentiment analytics for pharmaceutical customers.
- Veeva Systems: Veeva is the dominant cloud-based CRM and KOL management platform for the life sciences industry and is directly comparable to Neolytica's Ti Expert platform. The founder Badal Shah previously helped build Veeva's KOL mapping business, underscoring the direct competitive overlap in pharma KOL/HCP engagement software.
Broad incumbents
- Informa Pharma Intelligence: Informa Pharma Intelligence provides broad pharma data, clinical trial, and KOL intelligence products that compete with portions of Neolytica's data aggregation, especially around publications, trials, and expert profiling.
- Definitive Healthcare: Definitive Healthcare offers healthcare commercial intelligence including HCP, hospital, and KOL data for life sciences companies. It is a broader incumbent competing with Neolytica in HCP targeting and commercial analytics.
- IQVIA: IQVIA is a global life sciences services and technology incumbent offering broad commercial analytics, KOL identification, and HCP engagement solutions that overlap with Neolytica but serve a much wider portfolio of pharma and provider clients.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Neolytica social profiles
Digital presenceNeolytica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Neolytica leadership team
Management profileNumber of profiles
Profiles1 record
Neolytica funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Neolytica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Neolytica
What does Neolytica do?
Neolytica sells an AI-driven SaaS healthcare analytics platform that helps pharmaceutical and life sciences organizations identify, map, and engage Key Opinion Leaders (KOLs) and Health Care Professionals (HCPs). The platform combines AI/ML and NLP with 300+ medical experts for sentiment analysis across 100,000+ digital platforms, and includes compliance firewalls separating Medical Affairs and Commercial Marketing use cases. Its core products are Ti Expert (KOL mapping and engagement planning) and NotifyMe (real-time social listening and email alerts).
Is Neolytica a public or private company?
Neolytica is a private company. It is classified as corporate owned and is currently operating.
When was Neolytica founded?
Neolytica was founded in 2022. It employs 251 to 500 people.
Where is Neolytica based?
Neolytica is headquartered in Morristown, United States, in the North America region.
How does Neolytica make money?
One revenue line is on record: saaS Platform Subscriptions.
Who are Neolytica's main competitors?
Emerging players on record are Aktana and Komodo Health. Direct peers are Within3, Monocl, Alpha Sophia, H1 and Veeva Systems. Broad incumbents are Informa Pharma Intelligence, Definitive Healthcare and IQVIA.
Does Neolytica have an API?
No public API is recorded for Neolytica.
What industry is Neolytica in?
Neolytica's product category is Healthcare Analytics / Pharmaceutical KOL Intelligence Software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 513210 and its SIC code is 7372.